Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| PTAFR | P25105 | Platelet-activating factor receptor (PAF-R) (PAFr) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Allergic/hypersensitivity disorderAsthmaCardiac arrhythmia | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.50 | ||
| RHCE | P18577 | Blood group Rh(CE) polypeptide (Rh polypeptide 1) (RhPI) (Rh30A) (RhIXB) (Rhesus C/E antigens) (CD antigen CD240CE) | Blood group antigen proteinsCD markersDisease related genes | 11 | Fusion and delivery mediationMetabolism mediation | 2 | 0.50 | |||
| S13A5 | Q86YT5 | Na(+)/citrate cotransporter (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter) (Solute carrier family 13 member 5) | Disease related genesHuman disease related genesMetabolic proteins | 11 | Fusion and delivery mediation | 2 | 0.50 | |||
| S19A3 | Q9BZV2 | Thiamine transporter 2 (ThTr-2) (ThTr2) (Solute carrier family 19 member 3) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Fusion and delivery mediationMetabolism mediation | 2 | 0.50 | |||
| S36A4 | Q6YBV0 | Neutral amino acid uniporter 4 (Solute carrier family 36 member 4) | Metabolic proteinsPredicted membrane proteinsTransporters | 10 | Fusion and delivery mediationMetabolism mediation | 2 | 0.50 | |||
| S41A3 | Q96GZ6 | Solute carrier family 41 member 3 | Predicted membrane proteinsTransporters | 10 | Fusion and delivery mediation | 2 | 0.50 | |||
| S45A4 | Q5BKX6 | Polyamine-transporter SLC45A4 (Solute carrier family 45 member 4) | Predicted membrane proteinsTransporters | 12 | Fusion and delivery mediation | 2 | 0.50 | |||
| S67A1 | Q96BI1 | Solute carrier family 67 member A1 (Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene A protein) (Efflux transporter-like protein) (Imprinted multi-membrane-spanning polyspecific transporter-related protein 1) (Organic cation transporter-like protein 2) (ORCTL-2) (Solute carrier family 22 member 1-like) (Solute carrier family 22 member 18) (Tumor-suppressing STF cDNA 5 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 5 protein) (p45-Beckwith-Wiedemann region 1 A) (p45-BWR1A) | Disease related genesHuman disease related genesMetabolic proteins | 10 | Clinical-translation mediationFusion and delivery mediation | 2 | 0.50 | |||
| SC6A7 | Q99884 | Sodium-dependent proline transporter (Solute carrier family 6 member 7) | Metabolic proteinsPredicted membrane proteinsTransporters | 12 | Fusion and delivery mediationMetabolism mediation | 2 | 0.50 | |||
| SERC2 | Q96SA4 | Serine incorporator 2 (Tumor differentially expressed protein 2-like) | Predicted membrane proteins | 11 | Metabolism mediation | 2 | 0.50 | |||
| SLIK6 | Q9H5Y7 | SLIT and NTRK-like protein 6 | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | Bladder cancerUreteral cancer | Clinical-translation mediation | 2 | 0.50 | ||
| SO4C1 | Q6ZQN7 | Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (OATP-H) (Organic anion transporter M1) (OATP-M1) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20) | 12 | Cardiac arrhythmiaHeart failure | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.50 | |||
| SPP2B | Q8TCT7 | Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) (Intramembrane protease 4) (IMP-4) (Presenilin homologous protein 4) (PSH4) (Presenilin-like protein 1) | EnzymesPredicted membrane proteins | 9 | Fusion and delivery mediationReceptor-signaling mediation | 2 | 0.50 | |||
| SPTC2 | O15270 | Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) | 1 | Metabolism mediation | 2 | 0.50 | ||||
| SSR3 | P32745 | Somatostatin receptor type 3 (SS-3-R) (SS3-R) (SS3R) (SST3) (SSR-28) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Alzheimer diseaseCushing syndromeStomach cancer | Clinical-translation mediationReceptor-signaling mediation | 2 | 0.50 | ||
| STYK1 | Q6J9G0 | Tyrosine-protein kinase STYK1 (EC 2.7.10.2) (Novel oncogene with kinase domain) (Protein PK-unique) (Serine/threonine/tyrosine kinase 1) | EnzymesPredicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 2 | 0.50 | |||
| TIMD4 | Q96H15 | T-cell immunoglobulin and mucin domain-containing protein 4 (TIMD-4) (T-cell immunoglobulin mucin receptor 4) (TIM-4) (T-cell membrane protein 4) | Plasma proteinsPredicted membrane proteins | 1 | Clinical-translation mediationImmune mediation | 2 | 0.50 | |||
| TLR4 | O00206 | Toll-like receptor 4 (hToll) (CD antigen CD284) | CD markersFDA approved drug targetsHuman disease related genes | 1 | Allergic/hypersensitivity disorderDiabetes mellitusHepatitis virus infection | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.50 | ||
| TM101 | Q96IK0 | Transmembrane protein 101 (Putative NF-kappa-B-activating protein 130) | 8 | Immune mediationReceptor-signaling mediation | 2 | 0.50 | ||||
| TM139 | Q8IV31 | Transmembrane protein 139 | Predicted membrane proteinsTransporters | 1 | Other mediation | 2 | 0.50 | |||
| TMC5A | Q8N6Q1 | Transmembrane and coiled-coil domain-containing protein 5A | Predicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 2 | 0.50 | |||
| TMPS2 | O15393 | Transmembrane protease serine 2 (EC 3.4.21.122) (Serine protease 10) [Cleaved into: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain] | Cancer-related genesEnzymesPredicted intracellular proteins | 1 | COVID-19Middle East Respiratory SyndromeSevere acute respiratory syndrome | Clinical-translation mediationMetabolism mediation | 2 | 0.50 | ||
| TR10D | Q9UBN6 | Tumor necrosis factor receptor superfamily member 10D (Decoy receptor 2) (DcR2) (TNF-related apoptosis-inducing ligand receptor 4) (TRAIL receptor 4) (TRAIL-R4) (TRAIL receptor with a truncated death domain) (CD antigen CD264) | 1 | Immune mediation | 2 | 0.50 | ||||
| TRPV3 | Q8NET8 | Transient receptor potential cation channel subfamily V member 3 (TrpV3) (Vanilloid receptor-like 3) (VRL-3) | 6 | DepressionDiabetes mellitusPain | Clinical-translation mediationFusion and delivery mediation | 2 | 0.50 | |||
| ZNT1 | Q9Y6M5 | Proton-coupled zinc antiporter SLC30A1 (Solute carrier family 30 member 1) (Zinc transporter 1) | Metabolic proteinsPredicted membrane proteinsTransporters | 6 | Fusion and delivery mediationMetabolism mediation | 2 | 0.50 |